Evidence-based Treatment Options in Cannabis Dependency

被引:15
|
作者
Walther, Lisa [1 ]
Gantner, Andreas [2 ]
Heinz, Andreas [1 ,3 ]
Majic, Tomislav [3 ]
机构
[1] Charite, Dept Psychiat & Psychotherapy, Campus Mitte, Berlin, Germany
[2] Therapieladen eV, Berlin, Germany
[3] Charite, St Hedwig Hosp, Dept Psychiat & Psychotherapy, Charite Campus Mitte, Berlin, Germany
来源
DEUTSCHES ARZTEBLATT INTERNATIONAL | 2016年 / 113卷 / 39期
关键词
RANDOMIZED CONTROLLED-TRIAL; MULTIDIMENSIONAL FAMILY-THERAPY; COGNITIVE-BEHAVIORAL THERAPY; PLACEBO-CONTROLLED TRIAL; STUDENT MARIJUANA USE; DOUBLE-BLIND; USE DISORDERS; TREATMENT PROGRAM; MOTIVATIONAL ENHANCEMENT; BRIEF INTERVENTION;
D O I
10.3238/arztebl.2016.0653
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Now that the consumption of natural and synthetic cannabinoids is becoming more widespread, the specific treatment of cannabis-related disturbances is an increasingly important matter. There are many therapeutic options, and it is not always clear which ones are evidence-based and appropriate for use in a given clinical situation. Methods: This review is based on reports of pertinent randomized and controlled trials (RCTs) that were retrieved by a selective search in the PubMed and Cochrane databases. Results: Cognitive behavior therapy (CBT) combined with other techniques has been found to have a moderate to large effect (Cohen's d = 0.53-0.9) on the amount of cannabis consumed as well as on the level of psychosocial functioning or the dependence syndrome. Systemic multidimensional family therapy (MDFT) has been found beneficial for younger adolescents who consume large amounts of cannabis and have psychiatric comorbidities. Short-term interventions with motivational talk therapy have been found effective for patients with or without an initial desire to achieve cannabis abstinence. All of these psychotherapeutic interventions are effective at evidence level Ia. The administration of gabapentin had a weak effect (d = 0.26) on the quantity consumed and on abstinence (evidence level Ib). Withdrawal symptoms can be alleviated with cannabinoid-receptor antagonists (d = 0.223 and 0.481) (evidence level Ib). On the other hand, there is evidence that serotonergic antidepressants can worsen withdrawal manifestations and increase the likelihood of relapse. Conclusion: Psychotherapeutic techniques remain the foundation of treatment for cannabis dependence. No drug has yet been approved for the treatment of cannabis dependence because of the lack of scientific evidence. The rates of abstinence that are currently achieved, even with psychotherapy, are still only moderate. Further clinical studies are needed for the evaluation of combinations of various treatments that can meet the needs of individual patients.
引用
收藏
页码:653 / +
页数:9
相关论文
共 50 条
  • [1] Are there evidence-based treatment options for MCI?
    Froelich, L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S627 - S627
  • [2] Thinking Beyond Legalization: The Case for Expanding Evidence-Based Options for Cannabis Use Disorder Treatment in Canada
    Jutras-Aswad, Didier
    Le Foll, Bernard
    Bruneau, Julie
    Wild, T. Cameron
    Wood, Evan
    Fischer, Benedikt
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2019, 64 (02): : 82 - 87
  • [3] Evidence-based treatment options in metastatic pancreatic adenocarcinoma
    Boeck, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 113 - 113
  • [4] Evidence-based treatment options for allergic diseases in otolaryngology
    Klimek, L.
    Sperl, A.
    HNO, 2013, 61 (06) : 525 - 537
  • [5] Evidence-based rather than habit-based treatment options
    Yusuf Yazici
    Nature Reviews Rheumatology, 2012, 8 : 374 - 376
  • [6] Evidence-based pharmacological treatment options for ADHD in children and adolescents
    Mechler, Konstantin
    Banaschewski, Tobias
    Hohmann, Sarah
    Hage, Alexander
    PHARMACOLOGY & THERAPEUTICS, 2022, 230
  • [7] Evidence-Based Approach of Treatment Options for Postoperative Knee Pain
    Farr, Jack
    Jaggers, Ryan
    Lewis, Hal
    Plackis, Andreas
    Sim, Seung B.
    Sherman, Seth L.
    PHYSICIAN AND SPORTSMEDICINE, 2014, 42 (02): : 58 - 70
  • [8] Evidence-based assessment of treatment options for children with IgA nephropathies
    Wyatt, RJ
    Hogg, RJ
    PEDIATRIC NEPHROLOGY, 2001, 16 (02) : 156 - 167
  • [9] Evidence-based assessment of treatment options for children with IgA nephropathies
    R. J. Wyatt
    Ronald J. Hogg
    Pediatric Nephrology, 2001, 16 : 156 - 167
  • [10] Neurocognitive impairment and evidence-based treatment options in Bipolar disorder
    Fountoulakis, Konstantinos N.
    ANNALS OF GENERAL PSYCHIATRY, 2020, 19 (01)